151 related articles for article (PubMed ID: 21352322)
1. Morbilliform drug eruption due to pegylated α-interferon can show complete regression after switching to non-pegylated interferon.
Barut S; Yuksek J; Sezer E; Gunal O; Koseoglu D
J Dermatol; 2011 May; 38(5):479-81. PubMed ID: 21352322
[TBL] [Abstract][Full Text] [Related]
2. Allergic sensitization to pegylated interferon-α results in drug eruptions.
Meller S; Gerber PA; Kislat A; Hevezi P; Göbel T; Wiesner U; Kellermann S; Bünemann E; Zlotnik A; Häussinger D; Erhardt A; Homey B
Allergy; 2015 Jul; 70(7):775-83. PubMed ID: 25831972
[TBL] [Abstract][Full Text] [Related]
3. Severe allergic eczema due to pegylated alpha-interferon may abate after switching to daily conventional alpha-interferon.
Veldt BJ; Schalm SW; Janssen HL
J Clin Gastroenterol; 2007 Apr; 41(4):432. PubMed ID: 17413616
[No Abstract] [Full Text] [Related]
4. Pyoderma gangrenosum and exacerbation of psoriasis resulting from pegylated interferon alpha and ribavirin treatment of chronic hepatitis C.
Yurci A; Guven K; Torun E; Gursoy S; Baskol M; Akgun H; Ozbakir O; Yucesoy M
Eur J Gastroenterol Hepatol; 2007 Sep; 19(9):811-5. PubMed ID: 17700270
[TBL] [Abstract][Full Text] [Related]
5. Adverse skin reactions due to pegylated interferon alpha 2b plus ribavirin combination therapy in a patient with chronic hepatitis C virus.
Hashimoto Y; Kanto H; Itoh M
J Dermatol; 2007 Aug; 34(8):577-82. PubMed ID: 17683392
[TBL] [Abstract][Full Text] [Related]
6. Erythema gyratum repens induced by pegylated interferon alfa for chronic hepatitis C.
Rongioletti F; Fausti V; Parodi A
Arch Dermatol; 2012 Oct; 148(10):1213-4. PubMed ID: 23069974
[No Abstract] [Full Text] [Related]
7. A longitudinal cohort study of mucocutaneous drug eruptions during interferon and ribavirin treatment of hepatitis C.
Tavakoli-Tabasi S; Bagree A
J Clin Gastroenterol; 2012 Feb; 46(2):162-7. PubMed ID: 21814144
[TBL] [Abstract][Full Text] [Related]
8. Exacerbation of oral lichen planus lesions during treatment of chronic hepatitis C with pegylated interferon and ribavirin.
Grossmann Sde M; Teixeira R; de Aguiar MC; do Carmo MA
Eur J Gastroenterol Hepatol; 2008 Jul; 20(7):702-6. PubMed ID: 18679075
[TBL] [Abstract][Full Text] [Related]
9. [Cutaneous necrosis due to injection of interferon-alpha 2b in a patient with chronic hepatitis C].
Castellanos González M; Pérez Carreras M; Muñoz Gómez R; Castellano Tortajada G
Gastroenterol Hepatol; 2011 Oct; 34(8):584-5. PubMed ID: 21641684
[No Abstract] [Full Text] [Related]
10. Generalized flare of pustular psoriasis induced by PEGylated interferon-α2b therapy for chronic hepatitis C.
Wu MC; Lee JY
Australas J Dermatol; 2012 Nov; 53(4):e69-72. PubMed ID: 23157789
[TBL] [Abstract][Full Text] [Related]
11. [Side effect of pegylated-interferon treatment in chronic C hepatitis: agranulocytosis].
Halász T; Farkas A; Tolvaj G; Horváth G
Orv Hetil; 2006 Feb; 147(7):321-4. PubMed ID: 17489160
[TBL] [Abstract][Full Text] [Related]
12. Diffuse skin reaction in patient with hepatitis B, treated with two different formulations of pegylated interferon.
Milkiewicz P; Yim C; Pache I; Heathcote J
Can J Gastroenterol; 2005 Nov; 19(11):677-8. PubMed ID: 16292363
[TBL] [Abstract][Full Text] [Related]
13. Pegylated interferons for chronic hepatitis C virus infection: an indirect analysis of randomized trials.
Chou R; Carson S; Chan BK
J Viral Hepat; 2008 Aug; 15(8):551-70. PubMed ID: 18482285
[TBL] [Abstract][Full Text] [Related]
14. Reversible alopecia universalis secondary to PEG-interferon alpha-2b and ribavirin combination therapy in a patient with chronic hepatitis C virus infection.
Kartal ED; Alpat SN; Ozgunes I; Usluer G
Eur J Gastroenterol Hepatol; 2007 Sep; 19(9):817-20. PubMed ID: 17700271
[TBL] [Abstract][Full Text] [Related]
15. Reversible sudden sensorineural hearing loss during chronic hepatitis C treatment with pegylated interferon/ribavirin.
Papastergiou V; Skorda L; Lisgos P; Karatapanis S
Acta Gastroenterol Belg; 2011 Dec; 74(4):582-4. PubMed ID: 22319972
[No Abstract] [Full Text] [Related]
16. Cutaneous sarcoidosis associated with pegylated interferon alfa and ribavirin therapy in a patient with chronic hepatitis C.
Rogers CJ; Romagosa R; Vincek V
J Am Acad Dermatol; 2004 Apr; 50(4):649-50. PubMed ID: 15034524
[No Abstract] [Full Text] [Related]
17. The effects of pegylated interferon/lamivudine therapy on auditory functions in patients with chronic hepatitis B.
Eser Karlidag G; Karlidag T; Demirdag K; Keles E
Auris Nasus Larynx; 2011 Jun; 38(3):312-8. PubMed ID: 21216118
[TBL] [Abstract][Full Text] [Related]
18. Rash from hepatitis C treatment.
Tang DM; Ward L
Cleve Clin J Med; 2011 Jul; 78(7):472-4. PubMed ID: 21724930
[No Abstract] [Full Text] [Related]
19. Pegylated interferon alfa-induced sarcoidosis: two sides of the same coin.
Guilabert A; Bosch X; Julià M; Iranzo P; Mascaró JM
Br J Dermatol; 2005 Feb; 152(2):377-9. PubMed ID: 15727663
[No Abstract] [Full Text] [Related]
20. [Thyroid dysfunction in patients with chronic hepatitis C treated with pegylated interferon alpha].
Montero-Tinnirello J; de la Fuente-Aguado J; Rodríguez-Pecci MS; Fernández-Fernández FJ
Rev Clin Esp; 2011 Sep; 211(8):436-8. PubMed ID: 21546017
[No Abstract] [Full Text] [Related]
[Next] [New Search]
